Sengmany, K., Singh, J., Stewart, G. D., Conn, P. J., Christopoulos, A., & Gregory, K. J. (2016). Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery. Neuropharmacology.
Citação norma ChicagoSengmany, Kathy, Junaid Singh, Gregory D. Stewart, P. Jeffrey Conn, Arthur Christopoulos, and Karen J. Gregory. "Biased Allosteric Agonism and Modulation of Metabotropic Glutamate Receptor 5: Implications for Optimizing Preclinical Neuroscience Drug Discovery." Neuropharmacology 2016.
Citação norma MLASengmany, Kathy, et al. "Biased Allosteric Agonism and Modulation of Metabotropic Glutamate Receptor 5: Implications for Optimizing Preclinical Neuroscience Drug Discovery." Neuropharmacology 2016.